SEC Form 5 · accession 0001237899-18-000008
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arthur F Ryan
Director
Period of report
Dec 31, 2017
Accepted (ET)
Feb 5, 2018 · 4:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 5, 2017 | G | 2,500 | $0.00 | D | 33,000 | D | |
| Common Stock | May 5, 2017 | G | 1,000 | $0.00 | D | 32,000 | D |
Table II — derivative securities
No Table II lines on this filing.